-
Sector Analysis
NewCloud Computing Market Trends and Analysis by Infrastructure, Product/Service, Vertical, Enterprise Size Band and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Cloud Computing’ report can help: Understand the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Cloud Computing’ report different from...
-
Sector Analysis
HER2 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
HER2 tests Market Report Overview The HER2 tests market size was valued at $123.6 million in 2023. The HER2 tests market will grow at a CAGR of more than 1% from 2023 to 2033. HER2 Testing includes extracting a sample of tumor tissue in a procedure called biopsy, which may be either fine-needle aspiration biopsy, core needle or surgical biopsy. HER2 status can also be determined by next-generation sequencing and array comparative genomic hybridization (aCGH). HER2 tests Market Outlook 2023-2033...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA test market size was $4.3 million in 2023. The considerable increase in the incidence of breast and ovarian cancer will drive the BRCA tests market to grow at a CAGR of more than 3% during 2023-2033. Rates of BRCA1/2 testing have increased in recent years. This is due to a lowering in the costs associated with BRCA1/2 screening, increased public awareness, and the availability of PARP inhibitors to treat breast and ovarian cancer...
-
Sector Analysis
United States (US) Enterprise ICT Market Analysis and Future Outlook by Segments (Hardware, Software and IT Services)
US Enterprise ICT Market Overview The US enterprise ICT market size was pegged at $1,230.3 billion in 2022 and is expected to grow at a CAGR of more than 8% during 2022-2027 to $1,838.3 billion in 2027. The growth of ICT services in the US is being driven by the increasing digitization of the economy, the rise of emerging technologies, the growing importance of data, and the need for flexibility and agility. ICT services are creating jobs, boosting productivity, and...
-
Sector Analysis
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
EGFR Tests Market Report Overview The EGFR tests market size was $17.4 million in 2023 and it will grow at a CAGR of less than 1% during 2023-2033. Epidermal growth factor receptor gene (EGFR) tests are carried out to detect mutations within this receptor gene in non-small cell lung cancer tumor cells. The outcome of may determine if EGFR-targeted tyrosine kinase inhibitors such as gefitinib and erlotinib may be beneficial for treating non-small cell lung cancer (NSCLC). EGFR Tests Market...
-
Sector Analysis
BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BCR-ABL Tests Market Overview The BCR-ABL Tests market size was valued at $23.5 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Breakpoint Cluster Region - Tyrosine-Protein Kinase ABL1 fusion gene (BCR-ABL) tests are carried out to detect fusion gene mutations in patient tissue samples. The outcome may guide therapies to treat various cancers including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML). BCR-ABL Tests Market...
-
Sector Analysis
Prenatal Screening Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Prenatal Screening Market Report Overview The prenatal screening market size was $669.3 million in 2023 and will grow at a CAGR of more than 1% from 2023 to 2033. Pre-natal screening describes tests that detect potential problems that affect the viability and development of the fetus using both less invasive and more invasive sampling techniques. Prenatal Screening Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights into the Prenatal Screening Market Forecast, Download a Free Sample Report...
-
Product Insights
NewLyme Disease – Drugs In Development, 2024
Empower your strategies with our Lyme Disease – Drugs In Development, 2024 report and make more profitable business decisions. Lyme disease is a bacterial infection transmitted by a tick. Lyme disease is caused by the bacterium Borrelia burgdorferi. Symptoms include rash, fever, chills, fatigue, body aches, and headache. Risk factors include age, gender, and geographic location. Treatment includes antibiotics. The Lyme Disease drugs in development market research report provide comprehensive information on the therapeutics under development for Lyme Disease, complete with...
-
Sector Analysis
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
KRAS Tests Market Report Overview The KRAS tests market size was valued at $37.1 million in 2023 and will grow at a CAGR of more than 7% during 2023-2033. Kirsten rat sarcoma virus (KRAS) gene tests are carried out to detect gene mutations in patient tissue samples; the outcome of which may guide therapies to treat various cancers including colorectal cancer, certain lung cancers, and some leukemias. KRAS Tests Market Outlook 2023-2033 ($ Million) Buy Full Report for More Insights...
-
Sector Analysis
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
ALK Tests Market Report Overview The ALK Tests market size was valued at $27.3 million in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Anaplastic Lymphoma Receptor Tyrosine Kinase (ALK) gene tests are carried out to detect gene rearrangements within non-small cell lung cancer tumor cells, the outcome of which may guide therapies to treat non-small cell lung cancer (NSCLC). ALK Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for...